Corning Q3 Earnings Beat Expectations with 8% Core Sales Growth, Optical Communications Segment Shines
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 29 2024
0mins
Should l Buy GLW?
Source: Benzinga
Corning Inc's Q3 Performance: Corning reported a core sales growth of 8% year-on-year, reaching $3.73 billion, with core EPS of 54 cents surpassing estimates. Notable increases were seen in Optical Communications (36% growth) and Display Technologies (4% growth), while Specialty Materials and Environmental Technologies experienced declines.
Future Outlook and Agreements: The company anticipates fourth-quarter core sales of $3.75 billion and has secured a multi-year agreement with AT&T valued over $1 billion. Additionally, Corning aims to achieve a 20% operating margin by the end of 2026 through its updated "Springboard" plan.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GLW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GLW
Wall Street analysts forecast GLW stock price to fall
10 Analyst Rating
8 Buy
2 Hold
0 Sell
Strong Buy
Current: 135.970
Low
83.00
Averages
99.00
High
110.00
Current: 135.970
Low
83.00
Averages
99.00
High
110.00
About GLW
Corning Incorporated operates as an innovator in materials science. Its segments include Optical Communications, Display Technologies, Specialty Materials, Environmental Technologies, and Life Sciences. Its Optical Communications segment manufactures carrier network and enterprise network components for the telecommunications industry. Its Display Technologies segment manufactures glass substrates for flat-panel displays, including liquid crystal displays and organic light-emitting diodes. Its Specialty Materials segment manufactures products that provide material formulations for glass, glass ceramics and fluoride crystals for customer needs. Its Environmental Technologies segment manufactures ceramic substrates and filters for emission control systems in mobile applications. Its Life Sciences segment develops, manufactures and supplies laboratory products, including labware, equipment, media, serum and reagents, enabling workflow solutions for drug discovery and bioproduction.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Rally: The S&P 500 Index rose by 0.97%, the Dow Jones Industrial Average by 0.86%, and the Nasdaq 100 by 1.45%, reflecting growing investor confidence amid optimism that the Middle East conflict may soon conclude, which could stabilize global markets.
- Strong Economic Data: The US ADP employment change for March increased by 62,000, surpassing expectations of 40,000, while February retail sales rose by 0.6% month-over-month, indicating robust economic recovery that may influence Federal Reserve policy decisions.
- Interest Rate Outlook: Despite a mere 1% chance of a 25 basis point rate hike at the upcoming FOMC meeting, hawkish comments from St. Louis Fed President raised concerns about inflation and employment risks, potentially affecting investor sentiment and market dynamics.
- Divergent Stock Performances: Target Hospitality surged by over 37% after securing a multi-year contract worth over $550 million, while Nike fell by more than 13% due to revenue forecasts indicating a decline, highlighting varied market reactions to company-specific news.
See More
- Price Fluctuation Analysis: LGLV's 52-week low is $155.93, high is $189.91, and the latest trade price is $178.20, indicating significant price movement that may influence investor buying decisions.
- Technical Analysis Tool: Comparing the latest share price to the 200-day moving average can provide valuable insights for investors, aiding in market trend assessment and potential buying opportunities.
- ETF Trading Mechanism: Exchange-traded funds (ETFs) trade like stocks, where investors buy and sell 'units' that can be created or destroyed based on demand, impacting liquidity and market performance.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs helps identify those experiencing notable inflows or outflows, which can affect the underlying stocks held and influence overall market dynamics.
See More
- Strategic Partnership: Nvidia's collaboration with Marvell Technology aims to integrate Marvell's custom AI chips with Nvidia's AI computing ecosystem, which is expected to enhance Nvidia's market share in the custom AI chip sector, further solidifying its leadership in AI computing.
- Investment Strategy: Nvidia's $2 billion investment for a 2.5% stake in Marvell not only provides financial support for Marvell's future growth but also allows Nvidia to benefit from any potential Marvell deals, thereby increasing its competitiveness in the AI data center market.
- Technological Interconnectivity: By extending its NVLink technology to Marvell's custom processors, Nvidia is expected to improve product compatibility, attracting more enterprises to invest in AI data centers and expanding its total addressable market.
- Market Reaction: Following the announcement of the partnership, Nvidia's stock surged by 5.6%, indicating a positive market response to the collaboration, and despite a challenging overall market environment, this move could provide new momentum for Nvidia's future earnings growth.
See More
- Market Rally: The S&P 500 surged over 2% on Tuesday amid signs of potential de-escalation in the Iran conflict, reflecting investor optimism, although caution is still warranted regarding this signal.
- Eli Lilly Acquisition: Eli Lilly announced its acquisition of Centessa Pharmaceuticals for up to $7.8 billion, focusing on new treatments for excessive daytime sleepiness, with peak sales for its key asset cleminorexton projected to exceed $3 billion, further solidifying Lilly's position in neuroscience.
- Novo Nordisk Competition: Novo Nordisk launched a subscription program to lower prices on Wegovy, aiming to reclaim market share from Eli Lilly, which leads in the GLP-1 category, highlighting the need for continuous innovation to maintain competitive advantage.
- Analyst Ratings: Truist initiated coverage of Corning with a hold rating and a $125 price target, expressing optimism about its optical business growth while raising concerns over current valuations, indicating a cautious market outlook on Corning's future growth potential.
See More
- Collaboration Expansion: Corning and Meta broke ground on a new optical cable manufacturing facility in Hickory, North Carolina, marking a significant step in their up to $6 billion agreement aimed at accelerating the construction of advanced data centers in the U.S. to support Meta's AI objectives.
- Job Growth: The expansion is expected to increase Corning's employment in North Carolina by 15% to 20%, further solidifying the state's role as a manufacturing hub for optical fiber and cable while creating more quality jobs for the local community.
- Technological Innovation: Under the agreement, Corning will supply Meta with its latest innovations in optical fiber, cable, and connectivity solutions, ensuring a critical role in AI infrastructure and bolstering America's leadership in the AI sector.
- Long-term Partnership: As Corning celebrates its 175th anniversary, the company underscores the importance of its partnership with Meta, highlighting its ongoing investment in U.S. manufacturing and commitment to North Carolina's manufacturing leadership.
See More

- Divergent Market Performance: On Monday, the S&P 500 index fell by 0.39%, while the Nasdaq 100 hit a 7.75-month low, indicating market concerns over the Middle East situation, particularly exacerbated by a sell-off in chip stocks, which negatively impacted investor confidence.
- Declining Bond Yields: The 10-year T-note yield dropped by 8 basis points to 4.34%, reflecting market fears that the ongoing war in the Middle East could lead to fuel shortages, potentially suppressing expectations for Fed rate hikes and highlighting economic growth uncertainties.
- Rising Crude Oil Prices: Crude oil prices surged over 3% to a three-week high due to Iranian attacks on the Strait of Hormuz, indicating severe threats to global energy supply chains, which could lead to soaring prices in the future and impact the global economy.
- Weak Manufacturing Activity: The Dallas Fed manufacturing activity survey fell to -0.2, below the expected 2.0, reflecting signs of economic slowdown that could influence corporate investment decisions and future economic growth.
See More










